Top 10 Companies in Iodine-131 Market: Growth Outlook, Innovation Trends, and Forecast 2025–2031 Market Overview Global Iodine-131 market was valued at USD 1,859.21 thousand in 2023 and is projected to reach USD 2,578.25 thousand by 2030, growing at a CAGR of 5.06% from 2024 to 2030. North America is expected to grow from USD 653.88 thousand in 2023 to USD 891.04 thousand by 2030, with a CAGR of 4.78%. Asia-Pacific market is projected to grow from USD 477.07 thousand in 2023 to USD 677.56 thousand by 2030, at a CAGR of 5.46%. Iodine-131 (I-131) is a radioactive isotope extensively used in nuclear medicine, particularly in diagnosing and treating thyroid-related disorders such as hyperthyroidism and thyroid cancer. Produced in nuclear reactors, I-131 emits radiation as it decays and is known for its targeted therapeutic effects. Get FREE Sample of this Report at https://www.intelmarketresearch.com/download-free-sample/352/iodine Top Companies in Iodine-131 Market Jubilant DraxImage NTP IRE - IRE ELiT Isotope JSC Nordion POLATOM In 2023, the top three companies held approximately 61.93% of total market revenue, highlighting a consolidated market landscape. Market Segmentation By Type Solution Capsule By Application Medical Use Industrial Use Production by Region North America Europe Asia-Pacific Latin America Middle East & Africa Consumption by Region North America (U.S., Canada) Asia-Pacific (China, Japan, South Korea, Southeast Asia, India) Europe (Germany, France, U.K., Italy, Russia, Rest of Europe) Latin America (Mexico, Brazil, Rest of Latin America) Middle East & Africa (Turkey, GCC Countries) Market Drivers Rising Incidence of Thyroid Disorders The global rise in thyroid-related illnesses is driving the demand for Iodine-131 in both diagnostic imaging and therapeutic treatments. Advancements in Nuclear Medicine Technological advancements like PET/CT and SPECT/CT have improved precision, increasing the adoption of I-131. Increased Adoption of Targeted Therapy I-131 provides targeted treatment by selectively accumulating in thyroid tissues, reducing side effects and enhancing efficacy. Growing Geriatric Population The aging global population, more susceptible to thyroid conditions, contributes significantly to rising demand. Government Support and Healthcare Investments Investments in healthcare infrastructure and supportive policies for cancer treatment further propel market expansion. Expanding Role in Non-Thyroid Applications New research is uncovering I-131’s potential in treating non-thyroid cancers, widening the application base. Market Restraints Strict Regulatory Frameworks Handling radioactive materials involves navigating stringent international and regional safety regulations. Short Half-Life of Iodine-131 With a half-life of only 8 days, logistical and distribution challenges limit availability in remote regions. High Production Costs Sophisticated equipment and safety protocols increase production costs, affecting affordability. Side Effects and Health Risks Though effective, I-131 may cause nausea, fatigue, and radiation exposure risks, reducing patient preference in certain cases. Competition from Alternative Therapies Non-radioactive treatments like molecular and immunotherapy present competition in specific indications. Market Opportunities Rising Demand in Emerging Markets Asia-Pacific, Latin America, and Africa are witnessing growth in healthcare infrastructure and nuclear medicine facilities. Development of Advanced Radioisotope Production Techniques Enhanced production methods improve supply consistency and reduce operational costs. Integration of AI in Nuclear Medicine AI is improving diagnostic accuracy and personalizing treatment plans, boosting clinical outcomes with I-131. Expansion into Veterinary Medicine Growing usage in veterinary oncology for conditions like feline hyperthyroidism adds a new growth avenue. Collaborations Between Academia and Industry Joint R&D initiatives drive innovation, leading to new formulations and expanded applications. Focus on Sustainable Practices Efforts toward eco-friendly production and waste management systems increase sustainability and market attractiveness. Market Challenges Global Supply Chain Disruptions Reliance on specialized production facilities makes the market vulnerable to supply shocks from geopolitical issues or natural disasters. Lack of Infrastructure in Developing Regions Many regions lack necessary infrastructure like radiopharmacies and nuclear reactors to utilize I-131 efficiently. Radiation Safety Concerns Public perception and professional safety concerns surrounding radiation use may limit adoption. Competition from Other Isotopes Alternatives like Lutetium-177 and Yttrium-90 are gaining attention for certain cancers, diverting market share. Complex Licensing and Compliance Processes Navigating global compliance standards and obtaining licenses can be time-consuming and resource-intensive, delaying market expansion. Get the Complete Report & TOC at https://www.intelmarketresearch.com/chemicals-and-materials/352/iodine CONTACT US: 276 5th Avenue, New York , NY 10001,United States International: (+1) 646 781 7170 Email: help@intelmarketresearch.com Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports Related URL https://24marketresearchrani.blogspot.com/2025/06/top-10-companies-in-granulated-lime-in.html https://24marketresearchrani.blogspot.com/2025/06/top-10-companies-in-open-top-plastic.html https://24marketresearchrani.blogspot.com/2025/06/top-10-companies-in-hot-runner-market.html https://24marketresearchrani.blogspot.com/2025/06/top-10-companies-in-high-performance.html https://24marketresearchrani.blogspot.com/2025/06/top-10-companies-in-ultramarine-blue.html https://24marketresearchrani.blogspot.com/2025/06/top-10-companies-in-travel-management.html https://24marketresearchrani.blogspot.com/2025/06/top-10-companies-in-soh-spin-on.html https://24marketresearchrani.blogspot.com/2025/06/top-10-companies-in-resettable-pptc.html https://24marketresearchrani.blogspot.com/2025/06/top-10-companies-in-data-center-energy.html https://24marketresearchrani.blogspot.com/2025/06/top-10-companies-in-cigar-humidors.html